This podcast features a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference. Drawing on Dr Mellman’s extensive experience and current work at the Parker Institute for Cancer Immunotherapy, this conversation provides:
Insight into the scientific and clinical trajectory of immuno-oncology
Perspectives on the evolving role of collaboration and innovative partnership models like PICI
Discussion of the key opportunities and challenges shaping IO innovation at scale
A visionary outlook on what the next chapter of immuno-oncology could look like
Podden och tillhörande omslagsbild på den här sidan tillhör
Conference Forum. Innehållet i podden är skapat av Conference Forum och inte av,
eller tillsammans med, Poddtoppen.